Suspension of trading
Sector LAVA Therapeutics
Stocks
LVTX
NL0015000AG6
Biotechnology & Medical Research
|
Delayed
Nasdaq
16:00:00 2025-11-20 EST
|
5-day change | 1st Jan Change | ||
| 1.740 USD | -3.87% |
|
-.--% | - |
| 11-21 | Xoma Royalty Completes Acquisition of Lava Therapeutics | MT |
| 11-21 | Xoma Royalty announces closing of transactions to acquire LAVA Therapeutics N.V. | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.87% | -.--% | -.--% | -.--% | -.--% | +9.43% | +12.32% | -71.45% | - | 45.77M | |
| +2.64% | +6.45% | +0.07% | +8.27% | +8.63% | +12.39% | +38.40% | -15.77% | +216.13% | 47.97B | |
| +0.31% | +0.44% | +3.56% | +40.24% | +20.25% | +49.99% | +37.11% | +12.20% | +240.66% | 44.5B | |
| -1.66% | +5.44% | -2.23% | +5.52% | +155.18% | +341.18% | +619.72% | +609.18% | - | 43.93B | |
| +1.68% | +0.28% | -0.01% | +26.45% | +20.69% | +10.17% | +99.10% | +0.79% | +1,112.97% | 41.03B | |
| +0.51% | -0.61% | -6.80% | +7.47% | +3.43% | +5.18% | +46.87% | -18.93% | +132.36% | 29.85B | |
| +0.24% | -0.93% | +2.96% | +15.65% | +10.11% | +23.49% | +151.01% | +229.70% | +2,000.58% | 17.27B | |
| +0.02% | +9.34% | +33.23% | +46.32% | +44.49% | +8.59% | - | - | - | 15.34B | |
| +1.76% | +2.98% | +7.84% | +14.15% | +26.15% | +29.13% | +45.78% | -30.95% | +95.04% | 15.3B | |
| +1.98% | -3.08% | -7.12% | -12.68% | - | - | - | - | - | 14.82B | |
| +0.75% | +6.19% | +1.64% | +31.34% | +48.52% | +101.56% | +51.69% | -29.07% | +254.60% | 13.98B | |
| +1.87% | +2.92% | +2.64% | +0.88% | -4.23% | +6.77% | -29.37% | -34.27% | +125.81% | 13.3B | |
| -2.19% | +6.76% | +18.38% | +256.23% | +238.16% | +167.86% | +101.44% | +32.49% | +1,734.06% | 12.48B | |
| -0.14% | +0.07% | +0.23% | +2.28% | +23.31% | +38.85% | +6.62% | -40.66% | +166.84% | 11.39B | |
| -0.85% | -0.39% | -4.37% | +63.87% | +51.71% | +28.48% | +39.81% | -54.86% | - | 10.96B | |
| +0.34% | -4.23% | -4.62% | +3.08% | +44.83% | +92.63% | +688.04% | +85.28% | - | 9.31B | |
| +0.91% | -1.52% | -1.08% | +17.38% | +63.47% | +119.18% | +733.48% | +683.19% | +581.83% | 9.18B | |
| +2.01% | +0.76% | +4.66% | +13.40% | -4.68% | -2.45% | +1.85% | -21.54% | +42.59% | 9.14B | |
| +2.38% | -7.86% | -16.11% | -0.77% | -30.36% | +19.27% | +453.83% | +184.72% | +981.94% | 8.14B | |
| +2.69% | -2.84% | -15.77% | -17.16% | -1.48% | +454.39% | +1,073.29% | -5.15% | - | 7.84B | |
| Average | +0.56% | +0.88% | +0.86% | +26.10% | +37.80% | +79.79% | +231.72% | +84.16% | +591.18% | 18.79B | |
| Weighted average by Cap. | +0.72% | +2.26% | +1.10% | +24.73% | +42.85% | +81.38% | +193.47% | +105.08% | +545.47% |
- Stock Market
- Stocks
- LVTX Stock
- Sector LAVA Therapeutics
Select your edition
All financial news and data tailored to specific country editions
